Developing T cell cancer immunotherapy in the dog with lymphoma

20Citations
Citations of this article
82Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Immunotherapy is not a new concept for veterinary medicine; however, adoptive T cell therapy is a new area of research in humans and canines alike. In humans, T cell therapy has been used againstmany different tumor histologies, including lymphoma, melanoma, and colon cancer. Although in dogs this approach has currently only been applied to lymphoma, other tumor types are under investigation. There are many different strategies used to take advantage of cell-mediated antitumor properties of T cells. This review will discuss many of the current strategies used in both humans and canines in regards to adoptive T cell therapy. © The Author 2014. Published by Oxford University Press on behalf of the Institute for Laboratory Animal Research. All rights reserved.

Cite

CITATION STYLE

APA

O’Connor, C. M., & Wilson-Robles, H. (2014). Developing T cell cancer immunotherapy in the dog with lymphoma. ILAR Journal, 55(1), 169–181. https://doi.org/10.1093/ilar/ilu020

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free